Drivers of the downgrade include BHS’ second year of weak operating performance. The system recorded a $13.4 million operating loss and an 8 percent operating cash-flow margin in fiscal year 2014.
Other negative aspects of the health system’s credit profile considered for the downgrade include its overall decline in inpatient volumes and higher-than-average reliance on Medicare and Medicaid, which make up a combined 72 percent of BHS’ gross revenue.
BHS’ strengths were also considered for the rating downgrade such as its good market share, unrestricted cash balances and plans to affiliate with Aa2-rated Baptist Health South Florida in Miami.
More articles on healthcare finance:
Moody’s affirms Presbyterian Healthcare Services’ ‘A3’ bond rating
Fitch assigns ‘AA-‘ rating to Munson Healthcare’s bonds
Moody’s affirms Southeast Georgia Health System’s ‘A2’ bond rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
